This Week in VC retweeted
We’re going LIVE in 15 minutes with @shishirmehrotra, CEO of @Superhuman!
Tune in at 11 AM Central. Live links to watch in comments.
Isomorphic is in early talks to raise a fresh round of cash at a valuation of between $40B and $50B.
They use AI to design drug molecules, then license these designs to pharma companies while also pursuing their own in-house drug pipeline.
Dive into this raise at our @thisweekinvc Substack. Link in comments.
On Wednesday, Nous Research — the company behind the popular open-source Hermes Agent — confirmed a $90M Series B at a $1.5B valuation, bringing its total funding to $158M. In frothy AI terms, that’s a relatively modest raise.
We break down the open-source numbers and founder Ryan Teknium's personal takes on the use of Hermes on our Substack.
Link in comments.
Together, Munich’s RobCo and its employees sold around $40 million in shares, at a roughly $1 billion valuation, moving the robotics startup into the mythical realm of the unicorns. Back in January, the company raised $100 million in Series C funding at a $500 million valuation, so it has doubled in value so far this year.
Learn more in our Substack. Link in comments.
Instinct is free and won't run ads. So how will this $10B personal agent make money?
Founder @noahrshinn is plotting an Apple Pay-style take rate on transactions processed by your agent. (And they're already doing $1B in transactions per year.)
We're looking over the deal plus some insider takes on the mega-viral AI assistant in today's Substack post. thisweekinvc.substack.com/p/…
Ando is an AI-native Slack killer that you to treat your agents like co-workers with their own identities and inboxes. They still never take PTO, though. So that's a plus.
Get the full download on the newly-emerged @Accel-backed startup in today's Substack post and find out why @andocorporation thinks your company is probably doing agents wrong. thisweekinvc.substack.com/p/…





